Curetis' Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
. - Highly multiplexed panel covers up to 112 diagnostic targets - Third new panel developed within one year after IPO…
Fresenius has decided to focus on its four established business segments Fresenius Medical Care, Fresenius Kabi, Freseni…
The Belgian Ministry of Social Affairs and Public Health has added the trifunctional antibody Removab® (catumaxomab) fro…
The European Commission has broadened the existing approval of Fresenius Biotech's antibody Removab® (catumaxomab) to tr…
TRION Pharma GmbH announces today that the results from two different studies demonstrate catumaxomab's capacity to acti…
. - Sales €11.8 billion, +13% at actual rates, +10% in constant currency - EBIT €1.8 billion, +19% at actual rates, +1…
The trifunctional antibody Removab® (Catumaxomab) from Fresenius Biotech was awarded this year's Galenus von Pergamon Pr…